[HTML][HTML] Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays

E Gupta, M Bajpai, A Choudhary - Asian journal of transfusion …, 2014 - journals.lww.com
An estimated 3% of the world population is infected with Hepatitis C virus (HCV), a
hepatotropic RNA virus, transmitted primarily via the blood route. The major modes of …

Tackling the hepatitis C disease burden in Punjab, India

RK Dhiman, S Satsangi, GS Grover, P Puri - Journal of clinical and …, 2016 - Elsevier
Hepatitis C virus (HCV) is a globally prevalent pathogen and is a major cause of healthcare
burden in India. HCV poses a significant problem in the state of Punjab, India owing to the …

[HTML][HTML] Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors

WA Alashek, CW McIntyre, MW Taal - BMC infectious diseases, 2012 - Springer
Background Patients receiving maintenance haemodialysis (HD) are at higher risk for
acquiring Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections than the general …

Viral hepatitis: Indian scenario

S Satsangi, YK Chawla - medical journal armed forces india, 2016 - Elsevier
Viral hepatitis is a cause for major health care burden in India and is now equated as a
threat comparable to the “big three” communicable diseases–HIV/AIDS, malaria and …

Low-dose sofosbuvir is safe and effective in treating chronic hepatitis C in patients with severe renal impairment or end-stage renal disease

S Taneja, A Duseja, A De, M Mehta… - Digestive diseases and …, 2018 - Springer
Abstract Background and Aims There is sparse data on the use of Sofosbuvir based directly
acting antiviral (DAA) drug regimens in chronic hepatitis C (CHC) patients with chronic …

Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end‐stage renal disease on maintenance haemodialysis

S Taneja, A Duseja, M Mehta, A De, N Verma… - Liver …, 2021 - Wiley Online Library
Abstract Background & Aims There is emerging data on the use of Sofosbuvir‐based directly
acting antiviral (DAA) drug regimens in chronic hepatitis C (CHC) patients with end‐stage …

[HTML][HTML] Hepatitis B and C virus infections among patients with end stage renal disease in a low-resourced hemodialysis center in Vietnam: a cross-sectional study

CM Duong, DP Olszyna, ML McLaws - BMC public health, 2015 - Springer
Abstract Background Hemodialysis services in Vietnam are being decentralised outside of
tertiary hospitals. To identify the challenges to infection control standards for the prevention …

Sofosbuvir–velpatasvir fixed drug combination for the treatment of chronic hepatitis C infection in patients with end-stage renal disease and kidney transplantation

N Gaur, V Malhotra, D Agrawal, SK Singh… - Journal of clinical and …, 2020 - Elsevier
Introduction India is witnessing high hepatitis C virus (HCV) infection burden in patients of
chronic kidney disease. Due to unavailability of costly Kidney Disease Improving Global …

Profile of hepatitis B virus, hepatitis C virus, hepatitis d virus and human immunodeficiency virus infections in hemodialysis patients of a tertiary care hospital in …

G Mittal, P Gupta, B Thakuria, GK Mukhiya… - Journal of Clinical and …, 2013 - Elsevier
Background and aim Viral hepatitis and human immunodeficiency virus (HIV) infection are
important causes of morbidity and mortality in hemodialysis (HD) patients. The present study …

Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients

S Taneja, A Duseja, A De, V Kumar… - …, 2018 - Wiley Online Library
Aims The data regarding the treatment of chronic hepatitis C (CHC) in renal transplant
recipients is lacking from the A sia‐P acific region. The aim of the present study was to …